Bollard Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1
| Closed | – | – | 305 |
|
|
2025
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 286 |
|
|
2024
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 299 |
|
|
2024
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 304 |
|
|
2024
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 304 |
|
|
2024
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 309 |
|
|
2023
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 349 |
|
|
2023
Q3 | $0 | Sell |
1
-15
| -94% | – | ﹤0.01% | 613 |
|
|
2023
Q2 | $4K | Buy |
16
+15
| +1,500% | +$3.75K | ﹤0.01% | 447 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 294 |
|
|
2022
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 291 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 295 |
|
|
2022
Q2 | $0 | Sell |
1
-1,288
| -100% | – | ﹤0.01% | 384 |
|
|
2022
Q1 | $313K | Sell |
1,289
-200
| -13% | -$48.6K | 0.01% | 194 |
|
|
2021
Q4 | $388K | Buy |
1,489
+3
| +0.2% | +$782 | 0.01% | 183 |
|
|
2021
Q3 | $392K | Buy |
1,486
+2
| +0.1% | +$528 | 0.01% | 182 |
|
|
2021
Q2 | $366K | Buy |
1,484
+2
| +0.1% | +$493 | 0.01% | 179 |
|
|
2021
Q1 | $287K | Buy |
1,482
+1
| +0.1% | +$194 | 0.01% | 191 |
|
|
2020
Q4 | $315K | Hold |
1,481
| – | – | 0.01% | 170 |
|
|
2020
Q3 | $254K | Buy |
1,481
+1
| +0.1% | +$172 | 0.01% | 181 |
|
|
2020
Q2 | $284K | Buy |
+1,480
| New | +$284K | 0.01% | 166 |
|